Fulgent Oncology
Xanthe Neal is a Senior Vice President of Account Management at CSI Laboratories since April 2021, with extensive experience in strategic account management and product development across various leadership roles. Previously, Xanthe served as Executive Vice President at Care Services, LLC and held multiple executive positions at Optum, including Vice President of Account Management. Earlier in the career, Xanthe was a National Account Executive at Coventry Health Care, where responsibilities included managing operational relationships with international clients and developing sales strategies. Key skills include managing large client projects, implementing process improvements, developing strategic partnerships, and overseeing revenue growth strategies.
This person is not in any teams
This person is not in any offices
Fulgent Oncology
As a brand under Fulgent Genetics, Fulgent Oncology provides personalized cancer diagnostics services through CSI Laboratories and Inform Diagnostics, Fulgent Genetics subsidiaries. Together, our labs have helped pathologists and oncologists accurately diagnose and treat their patients for over 25 years. Our in-house medical team works closely with pathologists, oncologists and technicians to provide comprehensive diagnostic testing and analysis throughout the United States and Caribbean. We invest in an expert medical team, the right technology and equipment, and training to provide a higher level of service to customers. Our testing services include: Flow Cytometry, FISH, Cytogenetic Analysis, Histology and Molecular Genetics. We also provide hematopathology and surgical pathology consultations and second opinions to support diagnosis and treatment decisions. We understand the need to deliver accurate and fast test results and we are driven every day by our mission to provide personalized cancer diagnostics to support pathologists in providing care to cancer patients.